nimacimab glp-1 news Skye Bioscience Q2 2025 slides: targets obesity treatment gaps By Skye Bioscience Presenting at GLP-1-Based

Whether these improvements are sustained and confirmed at Phase 3 scale remains to be established

The relevance of these findings to humans is unknown

Individuals who follow a strict vegan diet are at a higher risk since they exclude animal products such as meat, fish, eggs, and milk, which are rich sources of B12

Tara *Based on internal survey 416 GLP-1 users in 2025 **Based on survey responses of 166 participants in a 6-month clinical trial who had overweight or obesity, and were taking semaglutide/tirzepatide for weight loss within the WW Clinic Program and participating in the GLP-1 companion nutrition program

Bech EM, Martos-Maldonado MC, Wismann P, et al